Characterization of the “Estrogenicity” of tamoxifen and raloxifene in HepG2 cells: Regulation of gene expression from an ERE controlled reporter vector versus regulation of the endogenous SHBG and PS2 genes

This publication has 53 references indexed in Scilit:

• Human estrogen receptor ligand activity inversion mutants: receptors that interpret antiestrogens as estrogens and estrogens as antiestrogens and discriminate among different antiestrogens
  Molecular Endocrinology, 1996
• Tripartite steroid hormone receptor pharmacology: interaction with multiple effector sites as a basis for the cell- and promoter-specific action of these hormones
  Molecular Endocrinology, 1996
• The carboxy-terminal F domain of the human estrogen receptor: role in the transcriptional activity of the receptor and the effectiveness of antiestrogens as estrogen antagonists
  Molecular Endocrinology, 1995
• Analysis of estrogen receptor function in vitro reveals three distinct classes of antiestrogens
  Molecular Endocrinology, 1995
• Human estrogen receptor transactivational capacity is determined by both cellular and promoter context and mediated by two functionally distinct intramolecular regions
  Molecular Endocrinology, 1994
• Transcriptional activation by the estrogen receptor requires a conformational change in the ligand binding domain
  Molecular Endocrinology, 1993
• Control of transcription activation by steroid hormone receptors
  The FASEB Journal, 1992
• Gene regulation by steroid hormones
  Cell, 1989
• Nuclear receptors enhance our understanding of transcription regulation
  Trends in Genetics, 1988
• The Steroid and Thyroid Hormone Receptor Superfamily
  Science, 1988